Cite
HARVARD Citation
Banerji, U. et al. (2019). Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study. Lancet oncology. 20 (8), pp. 1124-1135. [Online].